Ohio State Joins Coriell's Personalized Rx Project to Study Utility of Genomic Data in Patient Care
September 30, 2009
Ohio State Joins Coriell's Personalized Rx Project to Study Utility of Genomic Data in Patient Care
OSU Medical Center will enroll patients who agree to join Coriell's personalized medicine project under the guidance of their primary care physician. The partners will study the impact of using genomic information in treating chronic conditions.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Posting 11 Percent Revenue Growth in FY2011, Myriad Focuses on Growing MDx Pipeline
August 10, 2011 / Pharmacogenomics Reporter - Bar Harbor Biotech Developing qPCR-Based Colorectal Cancer Risk Test
April 28, 2011 / PCR Insider - Continuing Revenue Growth in Third Quarter, Myriad Keeps Focus on Diversifying MDx Product Portfolio
May 8, 2013 / Pharmacogenomics Reporter - With 8 Percent Revenue Bump in Q1, Genomic Health Focus on Expanding Oncotype DX Franchise
May 8, 2013 / Pharmacogenomics Reporter - Theradiag Expanding microRNA Assay Plans with HIV, Anti-Obesity CDx Agreement
May 2, 2013 / Gene Silencing News